Deep Track Capital, LP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital, LP | 1,900,000 4.000% | 1,334 (+0.07%) | Filing |
| 2021-04-22 5:56 pm Purchase | 2021-04-19 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital, LP | 1,898,666 5.050% | 1,898,666 (New Position) | Filing |